0013:HK HUTCHMED China Ltd

HKD 26.70 0.15 0.564972
Icon

HUTCHMED China Ltd (0013:HK) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | HK
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

HKD 26.70

+0.15 (+0.56)%

HKD 23.09B

2.81M

N/A

N/A

Icon

0013:HK

HUTCHMED China Ltd (HKD)
COMMON STOCK | HK
HKD 26.70
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

HKD 23.09B

N/A

HKD 26.70

HUTCHMED China Ltd (0013:HK) Stock Forecast

N/A

Based on the HUTCHMED China Ltd stock forecast from 0 analysts, the average analyst target price for HUTCHMED China Ltd is not available over the next 12 months. HUTCHMED China Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of HUTCHMED China Ltd is Slightly Bearish, which is based on 7 positive signals and 9 negative signals. At the last closing, HUTCHMED China Ltd’s stock price was HKD 26.70. HUTCHMED China Ltd’s stock price has changed by -3.09% over the past week, +7.88% over the past month and +26.84% over the last year.

No recent analyst target price found for HUTCHMED China Ltd
No recent average analyst rating found for HUTCHMED China Ltd

Company Overview HUTCHMED China Ltd

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell...Read More

https://www.hutch-med.com

Cheung Kong Center, Central, Hong Kong

1,988

December

HKD

Hong Kong

Adjusted Closing Price for HUTCHMED China Ltd (0013:HK)

Loading...

Unadjusted Closing Price for HUTCHMED China Ltd (0013:HK)

Loading...

Share Trading Volume for HUTCHMED China Ltd Shares

Loading...

Compare Performance of HUTCHMED China Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 0013:HK

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To HUTCHMED China Ltd (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
3692:HK
Hansoh Pharmaceutical Group Co.. +0.60 (+4.03%) HKD77.89B 27.38 17.27

ETFs Containing 0013

Symbol Name 0013's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About HUTCHMED China Ltd (0013:HK) Stock

Stock Target Advisor's fundamental analysis for HUTCHMED China Ltd's stock is Slightly Bearish.

Unfortunately we do not have enough data on 0013:HK's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 0013:HK's stock to indicate what its average analyst target is.

0013:HK stock's Price/Earning ratio is 28.78. Our analysis grades 0013:HK stock's Price / Earning ratio at F. This means that 0013:HK stock's Price/Earning ratio is above 86% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the HK exchange. Based on this 0013:HK may be a overvalued for its sector.

The last closing price of 0013:HK's stock was HKD 26.70.

The most recent market capitalization for 0013:HK is HKD 23.09B.

Unfortunately we do not have enough analyst data on 0013:HK's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains HUTCHMED China Ltd's stock.

As per our most recent records HUTCHMED China Ltd has 1,988 Employees.

HUTCHMED China Ltd's registered address is Cheung Kong Center, Central, Hong Kong. You can get more information about it from HUTCHMED China Ltd's website at https://www.hutch-med.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...